Haleon plc (NYSE:HLN) — Market Cap & Net Worth
Market Cap & Net Worth: Haleon plc (HLN)
Haleon plc (NYSE:HLN) has a market capitalization of $40.74 Billion ($40.74 Billion) as of September 23, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #680 globally and #324 in its home market, demonstrating a -1.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haleon plc's stock price $9.25 by its total outstanding shares 4403863311 (4.40 Billion). Also see total assets of Haleon plc for a full breakdown of the balance sheet.
Haleon plc Market Cap History: 2022 to 2026
Haleon plc's market capitalization history from 2022 to 2026. Data shows growth from $34.17 Billion to $40.74 Billion (5.91% CAGR). Also see how efficiently does Haleon plc generate cash for how efficiently the company converts equity into cash flow.
Haleon plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haleon plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check HLN stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.04x
Haleon plc's market cap is 4.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.31x
Haleon plc's market cap is 27.31 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $34.17 Billion | $10.86 Billion | $1.06 Billion | 3.15x | 32.24x |
| 2023 | $35.61 Billion | $11.30 Billion | $1.05 Billion | 3.15x | 33.95x |
| 2024 | $42.01 Billion | $11.23 Billion | $1.44 Billion | 3.74x | 29.14x |
| 2025 | $44.52 Billion | $11.03 Billion | $1.63 Billion | 4.04x | 27.31x |
Competitor Companies of HLN by Market Capitalization
Companies near Haleon plc in the global market cap rankings as of September 23, 2026. Review Haleon plc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Haleon plc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Galderma Group N (SW:GALD): Ranked #750 globally with a market cap of $37.01 Billion USD ( CHF29.28 Billion CHF).
- Teva Pharmaceutical Industries Limited (F:TEV): Ranked #796 globally with a market cap of $34.58 Billion USD ( €29.58 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #750 | Galderma Group N | SW:GALD | $37.01 Billion | CHF163.80 |
| #796 | Teva Pharmaceutical Industries Limited | F:TEV | $34.58 Billion | €28.60 |
Haleon plc Historical Marketcap From 2022 to 2026
Between 2022 and today, Haleon plc's market cap moved from $34.17 Billion to $ 40.74 Billion, with a yearly change of 5.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.74 Billion | -8.51% |
| 2025 | $44.52 Billion | +5.97% |
| 2024 | $42.01 Billion | +17.97% |
| 2023 | $35.61 Billion | +4.21% |
| 2022 | $34.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Haleon plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.74 Billion USD |
| MoneyControl | $40.74 Billion USD |
| MarketWatch | $40.74 Billion USD |
| marketcap.company | $40.74 Billion USD |
| Reuters | $40.74 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more